In-Silico Analysis and Protective Efficacy of the PcrV Recombinant Vaccine against Pseudomonas Aeruginosa in the Burned and PA-Infected BALB/c Mouse Model.
CONCLUSION: Our results demonstrated that the PcrV protein could be an effective candidate vaccine for the generation of antibody response against P. aeruginosa infection.
PMID: 32602466 [PubMed - in process]
Source: Iranian Journal of Immunology - Category: Allergy & Immunology Tags: Iran J Immunol Source Type: research
More News: Allergy & Immunology | Burns | Environmental Health | Gastroenteritis | Iran Health | Liver | Middle East Health | Pneomococcal Vaccine | Pneumonia | Respiratory Medicine | Skin | Study | Urology & Nephrology | Vaccines